| scholarly article | Q13442814 |
| P50 | author | Abrar A Qureshi | Q114301950 |
| P2093 | author name string | Hyon K Choi | |
| Joel M Gelfand | |||
| Elizabeth Wood Karlson | |||
| Thorvardur Jon Love | |||
| P2860 | cites work | Quality of life in patients with psoriasis | Q21245617 |
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey | Q29614468 | ||
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
| Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses | Q33767803 | ||
| Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database | Q33951592 | ||
| Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. | Q34478064 | ||
| Obesity as a cardiovascular risk factor | Q35609183 | ||
| Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence | Q36177005 | ||
| The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. | Q36602668 | ||
| Psoriasis and metabolic disease: epidemiology and pathophysiology | Q37102789 | ||
| Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. | Q37742713 | ||
| Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. | Q37753594 | ||
| Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese. | Q43224634 | ||
| The risk of mortality in patients with psoriasis: results from a population-based study | Q43414443 | ||
| Lipid profile, insulin secretion, and insulin sensitivity in psoriasis | Q44081933 | ||
| Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women | Q44907712 | ||
| Low prevalence of psoriasis in Norwegian lapps. | Q45240404 | ||
| Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus | Q45288103 | ||
| Insulin resistance and cigarette smoking | Q46042642 | ||
| Psoriasis and dyslipidaemia: a population-based study | Q46252334 | ||
| Effect of etanercept on insulin sensitivity in nine patients with psoriasis | Q46819537 | ||
| Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. | Q47207776 | ||
| Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. | Q47261263 | ||
| Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II. | Q47274479 | ||
| The prevalence of psoriasis in Denmark | Q50553121 | ||
| Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. | Q51008269 | ||
| Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). | Q51555318 | ||
| The prevalence of psoriasis in African Americans: results from a population-based study. | Q53313989 | ||
| A prospective study of cigarette smoking and the incidence of diabetes mellitus among us male physicians | Q57616858 | ||
| Prevalence of cardiovascular risk factors in patients with psoriasis | Q60711908 | ||
| Risk of Myocardial Infarction in Patients With Psoriasis | Q60711909 | ||
| Determinants of quality of life in patients with psoriasis: A study from the US population | Q61962649 | ||
| Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated with Widespread Treatment Dissatisfaction | Q61962663 | ||
| Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis | Q79190342 | ||
| Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study | Q80439172 | ||
| Psoriasis remission after laparoscopic Roux-en-Y gastric bypass for morbid obesity | Q80851043 | ||
| Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis | Q81050476 | ||
| Psoriasis | Q81716559 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 419-424 | |
| P577 | publication date | 2010-12-20 | |
| P1433 | published in | Archives of Dermatology | Q15749524 |
| P1476 | title | Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. | |
| P478 | volume | 147 |
| Q37170305 | A marriage of two "Methusalem" drugs for the treatment of psoriasis?: Arguments for a pilot trial with metformin as add-on for methotrexate. |
| Q48522422 | A multileveled approach in psoriasis assessment and follow-up: A proposal for a tailored guide for the dermatological practice |
| Q38935290 | Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations. |
| Q37408380 | An observational study on the obesity and metabolic status of psoriasis patients |
| Q38673766 | An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies |
| Q89981658 | Analysis of cardiovascular risk and carotid intima-media thickness in patients with psoriasis |
| Q42472471 | Anti-TNF-α therapy reduces retinol-binding protein 4 serum levels in non-diabetic patients with psoriasis: a 6-month prospective study. |
| Q51312247 | Are all patients with psoriasis at increased risk for coronary artery disease? |
| Q36885064 | Assessment of adiposity in psoriatic patients by dual energy X-ray absorptiometry compared to conventional methods |
| Q92109846 | Assessment of the Possible Role of FOXP3 Gene (rs3761548) Polymorphism in Psoriasis Vulgaris Susceptibility and Pathogenesis: Egyptian Study |
| Q89444391 | Association between physical activity and risk of prevalent psoriasis: A MOOSE-compliant meta-analysis |
| Q58293895 | Association between psoriasis and leisure-time physical activity: Findings from the National Health and Nutrition Examination Survey |
| Q36761374 | Association of pediatric psoriasis severity with excess and central adiposity: an international cross-sectional study. |
| Q41366968 | Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate-to-severe psoriasis undergoing anti-tumor necrosis factor-α therapy |
| Q89017592 | Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts |
| Q38076496 | Cardiovascular aspects of psoriasis: an updated review |
| Q40031011 | Cardiovascular risk factors in subjects with psoriasis: a cross-sectional general population study |
| Q37215912 | Carotid intima-media thickness in patients with mild or moderate psoriasis. |
| Q90564046 | Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report |
| Q37703699 | Circulating adiponectin levels in Indian patients with psoriasis and its relation to metabolic syndrome |
| Q51328259 | Clinical and laboratory parameters associated with metabolic syndrome in Turkish patients with psoriasis. |
| Q41053849 | Clinical symptoms and self-reported disease severity among patients with psoriasis - Implications for psoriasis management |
| Q48072913 | Comorbidities and health-related quality of life in Spanish patients with moderate to severe psoriasis: a cross-sectional study (Arizona study). |
| Q61808909 | Comorbidities in Lichen Planus: A Case-control Study in Indian Patients |
| Q48097375 | Comorbidity profiles of psoriasis in Taiwan: A latent class analysis. |
| Q38870692 | Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity. |
| Q55044800 | Current knowledge on psoriasis and autoimmune diseases. |
| Q39189237 | Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP). |
| Q44634537 | Diet and nutrition in psoriasis: analysis of the National Health and Nutrition Examination Survey (NHANES) in the United States |
| Q57244406 | Diet and physical exercise in psoriasis: a randomized controlled trial |
| Q38178202 | Does treatment of psoriasis reduce the risk of cardiovascular disease? |
| Q91816287 | ERAPSO: Revealing the High Burden of Obesity in German Psoriasis Patients |
| Q37268868 | Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis |
| Q35620533 | Effect of psoriasis activity on serum adiponectin and leptin levels. |
| Q35115207 | Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences |
| Q92840232 | Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study |
| Q41330230 | Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis. |
| Q22241921 | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association |
| Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
| Q40988865 | High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study |
| Q48106350 | High-fat diet exacerbates imiquimod-induced psoriasis-like dermatitis in mice |
| Q37672346 | Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis |
| Q39227956 | Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain |
| Q48294872 | Identification of PTPN22, ST6GAL1 and JAZF1 as psoriasis risk genes demonstrates shared pathogenesis between psoriasis and diabetes. |
| Q38580391 | Identifying Performance Gaps in Comorbidity and Risk Factor Screening, Prevention, and Counseling Behaviors of Providers Caring for Children with Psoriasis |
| Q48122586 | Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study |
| Q31098137 | Increased overall drug utilization in patients with psoriasis: a case-control study based on Dutch general practitioner data |
| Q34168423 | Increased prevalence of metabolic syndrome in patients with acne inversa |
| Q37987473 | Inflammation, atherosclerosis, and psoriasis. |
| Q34364602 | Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis |
| Q37054337 | Is psoriasis a new cutaneous marker for metabolic syndrome? A study in Indian patients |
| Q41880845 | Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients |
| Q37961072 | Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement |
| Q38095512 | Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis |
| Q38827236 | Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review. |
| Q37734265 | Metabolic Syndrome in Psoriasis among Urban South Indians: A Case Control Study Using SAM-NCEP Criteria |
| Q34409690 | Metabolic syndrome and its components in patients with psoriasis |
| Q39248840 | Metabolic syndrome in Moroccan patients with psoriasis |
| Q36897095 | Metabolic syndrome in patients with psoriatic disease. |
| Q36820863 | Obesity and the risk of psoriatic arthritis: a population-based study. |
| Q45741250 | Obstacles and solutions to screening psoriasis patients for cardiovascular risk factors |
| Q30234370 | Pediatric Psoriasis |
| Q42275529 | Possible association of hepatitis C virus infection with late-onset psoriasis: a hospital-based observational study |
| Q55270893 | Potential Immunological Links Between Psoriasis and Cardiovascular Disease. |
| Q36708804 | Prevalence of Metabolic Syndrome in Psoriasis Patients and its Relation to Disease Duration: A Hospital Based Case-Control Study |
| Q41515491 | Prevalence of Metabolic Syndrome in Psoriasis and Levels of Interleukin-6 and Tumor Necrosis Factor-α in Psoriasis Patients with Metabolic Syndrome: Indian Tertiary Care Hospital Study |
| Q36048427 | Prevalence of cardiovascular disease risk factors, and metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years |
| Q35809261 | Prevalence of chronic axial pain, inflammatory back pain, and spondyloarthritis in diagnosed psoriasis |
| Q47401344 | Prevalence of metabolic syndrome in Chinese psoriasis patients: A hospital-based cross-sectional study |
| Q36352320 | Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital-based case-control study |
| Q37644609 | Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study |
| Q35753936 | Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom |
| Q36299948 | Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys |
| Q39064240 | Prevalence of weight loss attempts and behaviors used by individuals with psoriasis in the United States population |
| Q37420435 | Primary care-based screening for cardiovascular risk factors in patients with psoriasis. |
| Q45352573 | Profile of patients with psoriasis associated with hepatitis C virus infection |
| Q35470124 | Psoriasis and cardiometabolic traits: modest association but distinct genetic architectures |
| Q89885278 | Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies |
| Q36185077 | Psoriasis and cardiovascular risk: strength in numbers, part II. |
| Q46386834 | Psoriasis and dyslipidemia: a population-based study analyzing the National Health and Nutrition Examination Survey (NHANES). |
| Q35601338 | Psoriasis and metabolic syndrome |
| Q37095225 | Psoriasis and risk of type 2 diabetes among women and men in the United States: a population-based cohort study |
| Q34643790 | Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis |
| Q37405750 | Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors. |
| Q93154858 | Risk Factors for the Development of Psoriasis |
| Q87736667 | Risk of Cardiovascular Outcomes among Psoriasis Patients Treated with Biologics and Other Systemic Agents |
| Q34323212 | Risk of cardiovascular disorders in psoriasis patients: current and future. |
| Q54273992 | Serum adiponectin and leptin levels in psoriatic patients according to topical treatment. |
| Q50776527 | Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients. |
| Q44274356 | Skin inflammation and cardiovascular health |
| Q48243210 | Sleep apnea as a comorbidity in obese psoriasis patients: a cross-sectional study. Do psoriasis characteristics and metabolic parameters play a role? |
| Q35096973 | Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis |
| Q47312304 | Subclinical atherogenesis in patients with mild psoriasis: A role for IL-6? |
| Q38097729 | Systematic review of UV-based therapy for psoriasis |
| Q47606183 | Systemic Inflammation, Oxidative Damage to Nucleic Acids, and Metabolic Syndrome in the Pathogenesis of Psoriasis |
| Q38056160 | The association between psoriasis and dyslipidaemia: a systematic review |
| Q48198816 | The relative impact of psoriasis and obesity on socioeconomic and medical outcomes in psoriasis patients. |
| Q44591858 | The role of pigment epithelium-derived factor as an adipokine in psoriasis |
| Q48232125 | Unmasking the Janus face of the association between psoriasis, metabolic syndrome and obstructive sleep apnea |
| Q30250110 | Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms |
| Q34773007 | Vitamin D and psoriasis pathology in the Mediterranean region, Valencia (Spain) |
| Q47319007 | Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. |
| Q36175745 | Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review. |
Search more.